MASH Epidemic & the Need for the ELF Test
The Need for Noninvasive Liver Fibrosis Tests
Assessment of liver fibrosis has traditionally relied on costly and invasive liver biopsy that requires a specialist, may not be representative of the amount of fibrosis, and carries a risk of life-threatening complications.


Identify risk of disease progression in advanced fibrosis due to MASH with a simple blood test
The ELF Test is a routine blood test proven to predict progression to cirrhosis and liver related events in patients with advanced fibrosis due to MASH1
- The only blood test with a prognostic claim in advanced fibrosis due to MASH
- Simplifies and accelerate the risk stratification of patients with advanced fibrosis due to NASH (MASH).
- Facilitates more timely prognostic assessments
- Available to all patients
The ELF Test enables accessible, effortless prognostic risk assessment in patients with advanced fibrosis due to NASH, improving patient care by stratifying those most at risk of progressing to cirrhosis and liver related events1
Learn more